Trinity Biotech

TRIB | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.35

+$0.12 (+1.66%)

At close: Sep 21, 2026, 4:00 PM ET

-$0.35 (-4.76%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.66%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $148.84M

1D Range

7.19 7.47

52W Range

6.85 52.50

Valuation (TTM)

PE -0.12

PB -2.07

EV/EBITDA -32.89

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -4.3%

SBC Adj. FCF Yield -4.3%

SBC Impact N/A

Margins

Gross Margin 35.4%

Operating Margin -25.7%

FCF Margin -14.5%

Growth (CAGR)

Revenue 3Y | 5Y -16.3% | -15.5%

Dil EPS 3Y | 5Y 22.4% | -4.8%

FCF 3Y | 5Y 36.0% | -19.7%

Returns

ROA -35.6%

ROE 68.1%

ROIC -15.1%

Financial Health

Net Debt

$122.01M

Current Ratio 0.25

Interest Coverage -0.53

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. ...

Sector Healthcare

Industry Medical - Specialties

Employees 287

IPO Date Oct 20, 1992

Website www.trinitybiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 10, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞